Pharma

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Welcome Renal Warriors

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

ACCELERATING WEB3 ADOPTION: ROLAND BERGER AND THE INACTA GROUP COOPERATE ON DIGITAL ASSETS AND WEB3 VENTURE BUILDING FOR THEIR CLIENTS

Zug, March 3, 2023. – Inacta Group, a leading Swiss IT solution provider with a venture building arm focused on blockchain enabled business models, and Roland Berger, a global strategy consulting firm, have disclosed that they are working on joint Web3 projects and intend to closely cooperate on many more in the future. One of the projects is for the German utility giant E.On which was announced in December 2022, another is for a pharma- and consumer goods giant based in Switzerland. Inacta is headquartered in Zug, Switzerland, in the

Molecule Partners with VitaDAO and Nevermined Creating Pioneering Biopharma IP-to-NFT Transfer

[Press Release – Please see Disclaimer] Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. 18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized

VET Geared For New Highs As VeChain Readies Latest Innovations

VeChain has seen a recent four-month rally, which only recently managed to die down. However, depending on the metrics you trust on the matter, a massive breakout event could happen, once more, which could see massive new highs for the currency. VeChain Getting The Best Of Things Of all the various cryptocurrencies the world has to offer thus far, VeChain stands as one that’s had a very good year of 2020. The pandemic may have caused a massive amount of chaos for the crypto industry at large, especially during Black

Africa Using Blockchain to Drive Change, Part Two: Southern Solutions

With pundits like Twitter CEO Jack Dorsey predicting that Africa “will define” the future of Bitcoin (BTC), cryptocurrency and blockchain technology continue to attract interest from both public and private establishments across the continent. Many of these adoption cases have been moving beyond finance, developing solutions targeted at issues like unemployment, identity management, health care and supply chain, among others.Amid the growing enthusiasm for crypto and blockchain technology in Africa, industry stakeholders interviewed by Cointelegraph identify a lack of education as one of the major hurdles standing in the way of more